Ibex

ibex is Revolutionizing the Utilities Marketplace with a Full Range of Customer Experience Solutions

Retrieved on: 
Thursday, March 23, 2023
Public utility, Pasta â Paolina, GameChanger, Home, Utility, CX, IOU, J.D. Power, Human voice, Service plan, DIY, Internet, Customer, Energy efficiency, CEM, BPO, Ibex, Digital, Voice of the customer, World News Connection, CSAT, Online shopping

WASHINGTON, March 23, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that major utilities across North America are benefiting from its end-to-end customer experience solution.

Key Points: 
  • WASHINGTON, March 23, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that major utilities across North America are benefiting from its end-to-end customer experience solution.
  • All told, ibex CX solutions for Utilities are helping major utilities transform the customer experience for more than 30 million households in North America.
  • “Forward-thinking utilities are embracing a new era of customer engagement, venturing beyond the confines of traditional commodity solutions to foster a more personal and innovative connection with their customers,” said Mark Wilkinson, SVP Products, ibex Digital.
  • “At ibex, we’re proud to be at the forefront of this transformation, empowering utilities to go beyond-the-meter and enrich the customer experience at every touchpoint along their journey.

ibex Partners With Krisp to Deliver a Better Customer and Agent Experience

Retrieved on: 
Thursday, March 9, 2023
Ibex, Part, BPO, AI, Human, SVP, Customer experience, AHT, Human voice, Agent, CSAT, CX, Noise, Communication, Sales, Mobile phone, Kniphofia

WASHINGTON, March 09, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it has partnered with Krisp to leverage Krisp’s cutting-edge AI-powered noise cancellation software for its onsite and remote agents to deliver a better customer experience.

Key Points: 
  • WASHINGTON, March 09, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it has partnered with Krisp to leverage Krisp’s cutting-edge AI-powered noise cancellation software for its onsite and remote agents to deliver a better customer experience.
  • “AI technology is changing the CX industry and empowering a better agent and customer experience,” said Jim Ferrato, Chief Information Officer at ibex.
  • “We are delighted to partner with ibex and deploy Krisp as part of their Wave X platform,” said Davit Baghdasaryan, Co-founder and CEO of Krisp.
  • With Krisp, ibex will again raise the bar on creating amazing customer experiences for the world’s top brands.”
    On March 16, ibex and Krisp will team up for Part 1 of ibex’s Wave X Technology Webinar Series: "Evolving The Agent and Customer Experience With The Power of AI".

Ibex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer Diagnosis

Retrieved on: 
Thursday, March 9, 2023
Physician, Hospital, Diagnosis, Health, Artificial intelligence, Patient, IHC, Breast, Growth, Prostate, TEL, Laboratory, Philips, Partnership, Cancer, Pathology, Caregiver, AI, Marie Cassidy, Suite, Medical device, Medical imaging, Ibex, Alverno Heights Academy

HAMMOND, Indiana and TEL AVIV, Israel, March 9, 2023 /PRNewswire/ -- Alverno Laboratories, a provider of high-quality diagnostic testing services and one of the largest integrated laboratory networks in the United States, and Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, today announced a new agreement to expand the deployment of Ibex's Galen™ suite of Artificial Intelligence (AI) solutions to the entire Alverno network across Illinois and Indiana. The deployment includes AI-powered solutions for cancer diagnosis across multiple tissue types and will support Alverno pathologists in providing the utmost quality of care for their patients.  

Key Points: 
  • The deployment includes AI-powered solutions for cancer diagnosis across multiple tissue types and will support Alverno pathologists in providing the utmost quality of care for their patients.
  • Under the new expansion agreement, Alverno will make Ibex's solutions available to all pathologists in its network, which includes more than 30 hospital laboratories and touches over eight million patients' lives per year across Indiana and Illinois.
  • "Alverno will expand the reach of Ibex's AI technology across our network, providing the most innovative tools to our team of pathologists.
  • With an increasing demand for high-quality cancer testing, Alverno continues to invest in technology to support our growth while remaining focused on high quality patient care," said Sam Terese, CEO & President of Alverno Laboratories.

Ibex Secures PathLAKE Contracts to Roll Out AI-based Cancer Diagnostics to UK Hospitals

Retrieved on: 
Tuesday, March 7, 2023
Trust, Hospital, Trust law, Prostate cancer, Diagnosis, Wales, Addenbrooke's Hospital, Artificial intelligence, Consultant, Innovate UK, Breast, Prostate, Woman, TEL, Nottingham University Hospitals NHS Trust, Cambridge University Hospitals NHS Foundation Trust, Cancer, Laboratory, University Hospitals Coventry and Warwickshire NHS Trust, Innovation, Pathology, University, AI, Oxford University Hospitals NHS Foundation Trust, Marie Cassidy, Digital pathology, Addenbrooke, Megaproject, Medical device, Medical imaging, Ibex, NHS Wales

TEL AVIV, Israel , March 7, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced the receipt of multiple contract awards from the PathLAKE consortium  to provide Artificial Intelligence (AI) solutions to support cancer diagnosis at 25 NHS Trusts.

Key Points: 
  • TEL AVIV, Israel , March 7, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced the receipt of multiple contract awards from the PathLAKE consortium  to provide Artificial Intelligence (AI) solutions to support cancer diagnosis at 25 NHS Trusts.
  • PathLAKE is a UK center of excellence consortium, founded by Innovate UK, that is delivering AI innovation in pathology across leading NHS Trusts and UK universities including Nottingham University Hospitals, University Hospitals Coventry & Warwickshire, and Oxford University Hospitals.
  • Cambridge University Hospitals is one of the Trusts to subsequently select Ibex to support its pathologists by augmenting diagnostic workflows with enhanced quality, accuracy and efficiency.
  • "We are extremely honored to be recognized by PathLAKE as the leading provider of AI solutions in pathology," said Richard Nicholson, Director of Sales, UK at Ibex.

Ibex Scoops Second Win of The UK Artificial Intelligence Award with Leading NHS Trusts

Retrieved on: 
Monday, March 6, 2023
North West Anglia NHS Foundation Trust, Social work, Trust, Hospital, Prostate cancer, University Hospitals Cleveland Medical Center, Diagnosis, Betsi Cadwaladr University Health Board, University of Nottingham, University, Artificial intelligence, TEL, Imperial College London, Deep learning, Nottingham University Hospitals NHS Trust, Patient, Cambridge University Hospitals NHS Foundation Trust, Cancer, NHS foundation trust, National Health Service, University Hospitals Coventry and Warwickshire NHS Trust, University Hospitals Birmingham NHS Foundation Trust, Breast cancer, Government, Pathology, Oxford University Press, Entrepreneurship, UK Health Security Agency, Doctor of Philosophy, Marie Cassidy, Nursing, University College London, NIHR, NHS, Pharmaceutical industry, Medical imaging, Ibex, Health, AI, Nature

TEL AVIV, Israel, March 6, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, University of Nottingham and a consortium of NHS Trusts, announced today they are winners of the UK Artificial Intelligence in Health and Care Award, enabling the deployment of Ibex's Galen™ Breast solution across five National Health Services (NHS) and delivering on their aligned missions of improving breast cancer diagnosis and lab efficiency.

Key Points: 
  • Galen Breast supports pathologists by providing AI-based tools and insights that help detect and grade different types of breast cancer.
  • The solution will be deployed at Nottingham University Hospitals, Cambridge University Hospitals, North West Anglia NHS Foundation Trust, Betsi Cadwaladr University Health Board and University Hospitals Birmingham.
  • Timely and accurate diagnosis can significantly impact breast cancer survival rates, making Ibex's solution a vital and welcome addition into NHS trusts."
  • "We are proud to receive this award from the NIHR and NHS, said Chaim Linhart, PhD, Co-Founder and Chief Technology Officer of Ibex Medical Analytics.

ibex to Sponsor the Execs In The Know Customer Response Summit – Austin 

Retrieved on: 
Thursday, March 2, 2023
CRS, CX, BPO, Ibex, Harvard Innovation Labs, Culture, Knowledge

AUSTIN, Texas, March 02, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced its sponsorship of the Customer Response Summit (CRS) – Austin , an Execs In The Know event, March 1-3, 2023. ibex will also host an Innovation Lab to showcase live customer experience (CX) applications in action, and demonstrate how they can be applied across different channels and processes.

Key Points: 
  • AUSTIN, Texas, March 02, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced its sponsorship of the Customer Response Summit (CRS) – Austin , an Execs In The Know event, March 1-3, 2023. ibex will also host an Innovation Lab to showcase live customer experience (CX) applications in action, and demonstrate how they can be applied across different channels and processes.
  • “We are delighted to be one of the sponsors of the Execs In The Know Customer Response Summit in Austin, and look forward to meeting industry thought leaders and sharing practices for delivering amazing CX,” said John Thompson, Global Head of Sales at ibex.
  • “In this challenging economic environment, brands have recognized the benefits of enhancing their CX to deliver greater customer value, satisfaction and retention.
  • A team of ibex CX experts will be on site to share best practices and the latest solutions to improve customer interactions, contact center performance, and client outcomes, all while reducing operating costs.

Frost & Sullivan Names ibex CX Outsourcing Services Leader

Retrieved on: 
Thursday, February 23, 2023
Ibex, Automation, Growth, BPO, CX, Wave, Frost, Radar, Retail, Drug

WASHINGTON, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it was named a Leader by Frost & Sullivan in the 2022 Frost Radar™: Customer Experience Outsourcing Services in Latin America.

Key Points: 
  • WASHINGTON, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it was named a Leader by Frost & Sullivan in the 2022 Frost Radar™: Customer Experience Outsourcing Services in Latin America.
  • The Frost Radar measures CX companies based on performance in terms of growth and innovation and ranked ibex as a market leader for the second year in a row.
  • "ibex is proud to be recognized by Frost & Sullivan as a CX Leader, which is the direct result of our unique agent-first culture, award-winning Wave X technology platform and relentless focus on delivering amazing customer experiences for our clients,” said ibex CEO Bob Dechant.
  • “The CX outsourcing services landscape is evolving with the adoption of digital technologies, and ibex has emerged as a CX Leader thanks to its innovative Wave X platform and strong expertise in digital and automation solutions,” said Sebastian Menutti, Industry Principal, Customer Experience at Frost & Sullivan.

ibex Teams Up With CareFirst to Support the 2023 CIAA Basketball Tournament in Baltimore

Retrieved on: 
Wednesday, February 22, 2023
CMO, Ibex, City, CareFirst BlueCross BlueShield, Athlete, BPO, Central Intercollegiate Athletic Association, CIAA, NCAA, Baltimore metropolitan area

BALTIMORE, Feb. 22, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced its support of the 2023 CIAA (Central Intercollegiate Athletic Association) Men’s and Women’s Basketball Tournament February 21-25 in Baltimore.

Key Points: 
  • BALTIMORE, Feb. 22, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced its support of the 2023 CIAA (Central Intercollegiate Athletic Association) Men’s and Women’s Basketball Tournament February 21-25 in Baltimore.
  • The CIAA is the nation’s oldest historically black athletic conference, and its annual basketball tournament is one of the most highly attended basketball tournaments among all NCAA divisions.
  • “ibex is proud to partner with CareFirst BlueCross BlueShield to support the 2023 CIAA Tournament , the City of Baltimore, and the outstanding athletes competing for the championship,” said ibex CMO and Chief Strategic Accounts Officer Julie Casteel.
  • "Like ibex, CareFirst is committed to diversity and inclusion, and we are excited to invest in the tournament's success and the Greater Baltimore region."

IBEX Limited Announces Strong Second Quarter of Fiscal Year 2023 Financial Results with Accelerating Adjusted EBITDA, Strong Revenue Growth and Cash Flow; Raises Adjusted EBITDA Guidance

Retrieved on: 
Wednesday, February 15, 2023
2.0, BPO, EBITDA, International Accounting Standards Committee, Annual report, Ibex, Fintech, IASB, Borrowing base, Association of British HealthTech Industries, Video game, Pharmaceutical industry, Payment card, Security (finance), Cryptocurrency, Bank, Tobacco

WASHINGTON, Feb. 15, 2023 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”), a leading global provider in business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its second quarter ended December 31, 2022.

Key Points: 
  • Revenue generated from BPO 2.0 clients grew 16.9% compared to the prior year quarter and represented 77.3% of total revenue in the second quarter.
  • Second quarter non-GAAP adjusted EBITDA increased 40.5% to $25.1 million over the prior year quarter.
  • Second quarter non-GAAP adjusted EBITDA margin increased to 18.0%, compared to 13.5% in the prior year quarter.
  • Net cash flow from operations in the second quarter increased to $8.3 million, compared to $3.4 million in the prior year quarter.

Ibex's Galen™ Prostate Becomes First Standalone AI-Powered Cancer Diagnostics Solution to Obtain CE Mark Under the IVDR

Retrieved on: 
Thursday, February 9, 2023
Prostate, TEL, Laboratory, CE, Breast, Quality, Regulatory affairs, Diagnosis, Quality assurance, Safety, IVDR, Patient, IVDD, Pathology, Marie Cassidy, Marketing, Ibex, Gleason, Subjectivity, Journal of Diagnostic Medical Sonography, European, AI, Medical device, Medical imaging, EU

TEL AVIV, Israel, Feb. 9, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galen™ Prostate is now CE marked under the In Vitro Diagnostic Medical Devices Regulation (IVDR) for supporting pathologists in primary diagnosis of prostate biopsies. Galen Prostate is the first standalone AI-based cancer diagnostics product of its kind certified under the IVDR. 

Key Points: 
  • TEL AVIV, Israel, Feb. 9, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galen™ Prostate is now CE marked under the In Vitro Diagnostic Medical Devices Regulation (IVDR) for supporting pathologists in primary diagnosis of prostate biopsies.
  • Galen Prostate is the first standalone AI-based cancer diagnostics product of its kind certified under the IVDR.
  • IVDR is the new regulatory standard set by the European Union, replacing the previous In Vitro Diagnostic Medical Device Directive (IVDD).
  • Galen Prostate received its IVDR CE certificate following a rigorous review demonstrating the quality of the product and its meticulous development process, safety, and performance.